Swiss National Bank
EW icon

Swiss National Bank’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$139M Buy
1,773,100
+109,600
+7% +$8.57M 0.08% 209
2025
Q1
$121M Sell
1,663,500
-38,300
-2% -$2.78M 0.09% 212
2024
Q4
$126M Sell
1,701,800
-86,800
-5% -$6.43M 0.08% 202
2024
Q3
$118M Buy
1,788,600
+8,300
+0.5% +$548K 0.08% 231
2024
Q2
$164M Sell
1,780,300
-36,000
-2% -$3.33M 0.11% 149
2024
Q1
$174M Sell
1,816,300
-84,700
-4% -$8.09M 0.12% 151
2023
Q4
$145M Sell
1,901,000
-48,900
-3% -$3.73M 0.11% 173
2023
Q3
$135M Sell
1,949,900
-239,100
-11% -$16.6M 0.11% 169
2023
Q2
$206M Sell
2,189,000
-264,600
-11% -$25M 0.14% 127
2023
Q1
$203M Sell
2,453,600
-66,000
-3% -$5.46M 0.14% 131
2022
Q4
$188M Sell
2,519,600
-174,825
-6% -$13M 0.14% 142
2022
Q3
$223M Sell
2,694,425
-9,800
-0.4% -$810K 0.16% 117
2022
Q2
$257M Buy
2,704,225
+100
+0% +$9.51K 0.17% 107
2022
Q1
$318M Buy
2,704,125
+334,900
+14% +$39.4M 0.18% 99
2021
Q4
$307M Sell
2,369,225
-88,800
-4% -$11.5M 0.18% 97
2021
Q3
$278M Sell
2,458,025
-88,500
-3% -$10M 0.18% 101
2021
Q2
$264M Buy
2,546,525
+149,716
+6% +$15.5M 0.16% 111
2021
Q1
$200M Buy
2,396,809
+48,600
+2% +$4.06M 0.13% 140
2020
Q4
$214M Sell
2,348,209
-63,800
-3% -$5.82M 0.15% 125
2020
Q3
$193M Sell
2,412,009
-64,900
-3% -$5.18M 0.15% 128
2020
Q2
$171M Buy
2,476,909
+1,667,406
+206% +$115M 0.14% 133
2020
Q1
$153M Buy
809,503
+153,800
+23% +$29M 0.16% 132
2019
Q4
$153M Sell
655,703
-32,800
-5% -$7.65M 0.16% 134
2019
Q3
$151M Buy
688,503
+10,505
+2% +$2.31M 0.16% 136
2019
Q2
$125M Sell
677,998
-19,700
-3% -$3.64M 0.14% 161
2019
Q1
$133M Buy
697,698
+17,000
+2% +$3.25M 0.15% 148
2018
Q4
$104M Buy
680,698
+7,700
+1% +$1.18M 0.13% 162
2018
Q3
$117M Sell
672,998
-21,600
-3% -$3.76M 0.13% 168
2018
Q2
$101M Buy
694,598
+15,700
+2% +$2.29M 0.12% 186
2018
Q1
$94.7M Sell
678,898
-99,800
-13% -$13.9M 0.12% 190
2017
Q4
$87.8M Buy
778,698
+3,500
+0.5% +$394K 0.09% 226
2017
Q3
$84.7M Sell
775,198
-700
-0.1% -$76.5K 0.1% 227
2017
Q2
$91.7M Buy
775,898
+18,400
+2% +$2.18M 0.11% 208
2017
Q1
$71.3M Buy
757,498
+164,500
+28% +$15.5M 0.09% 241
2016
Q4
$55.6M Buy
592,998
+4,100
+0.7% +$384K 0.09% 250
2016
Q3
$71M Sell
588,898
-12,700
-2% -$1.53M 0.11% 202
2016
Q2
$60M Buy
601,598
+41,100
+7% +$4.1M 0.1% 234
2016
Q1
$47.4M Buy
560,498
+171,300
+44% +$14.5M 0.09% 257
2015
Q4
$30.7M Buy
389,198
+197,249
+103% +$15.6M 0.07% 282
2015
Q3
$27.3M Buy
191,949
+18,200
+10% +$2.59M 0.07% 298
2015
Q2
$24.7M Buy
173,749
+10,800
+7% +$1.54M 0.06% 323
2015
Q1
$23.2M Buy
162,949
+64,600
+66% +$9.2M 0.06% 333
2014
Q4
$12.5M Sell
98,349
-3,300
-3% -$420K 0.05% 372
2014
Q3
$10.4M Sell
101,649
-2,800
-3% -$286K 0.04% 413
2014
Q2
$8.97M Sell
104,449
-1,800
-2% -$155K 0.03% 472
2014
Q1
$7.88M Sell
106,249
-13,300
-11% -$986K 0.03% 496
2013
Q4
$7.86M Sell
119,549
-2,700
-2% -$178K 0.03% 507
2013
Q3
$8.51M Buy
122,249
+800
+0.7% +$55.7K 0.04% 467
2013
Q2
$8.16M Buy
+121,449
New +$8.16M 0.04% 446